| |
| |
|
| Insider
Information: |
Zulueta Alfonso G |
| Relationship: |
Director |
| City: |
Indianapolis |
| State: |
IN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
228,617 |
|
|
Indirect Shares
|
4,667 |
|
|
| Direct
Value |
$45,815,840 |
|
|
|
Indirect Value
|
$3,593,590 |
|
|
| Total
Shares |
233,284 |
|
|
| Total
Value |
$49,409,430 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
5
|
0
|
|
Stock
price went up :
|
5
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
5.0
|
0.0
|
| Percentage
Gain/Loss : |
 35.5%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Eli Lilly & Co |
LLY |
SVP & President, Lilly... |
2021-02-08 |
56,947 |
2021-02-08 |
4,667 |
Premium* |
|
|
CTS Corp |
CTS |
Director |
2023-11-02 |
30,013 |
2018-11-08 |
0 |
Premium* |
|
|
Syneos Health Inc |
SYNH |
Director |
2023-05-25 |
8,356 |
2022-01-18 |
0 |
Premium* |
|
|
First Light Acquisition Group, I... |
FLAG |
Director |
2023-12-21 |
133,301 |
2023-12-21 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
56 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LLY |
Eli Lilly & Co |
SVP& Pres., Emerging Markets |
• – – |
2014-01-28 |
4 |
A |
$54.23 |
$614,589 |
D/D |
11,333 |
34,163 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP& Pres., Emerging Markets |
• – – |
2015-01-28 |
4 |
A |
$70.97 |
$818,426 |
D/D |
11,532 |
52,692 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP& Pres., Emerging Markets |
• – – |
2016-01-26 |
4 |
A |
$81.96 |
$576,589 |
D/D |
7,035 |
62,101 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP& Pres., Emerging Markets |
• – – |
2017-01-27 |
4 |
A |
$75.38 |
$991,247 |
D/D |
13,150 |
57,051 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & President, Lilly Intl |
• – – |
2018-01-29 |
4 |
A |
$87.60 |
$816,082 |
D/D |
9,316 |
49,364 |
0 |
- |
|
| CTS |
CTS Corp |
Director |
– • – |
2018-11-08 |
4 |
A |
$28.85 |
$121,170 |
D/D |
4,200 |
4,200 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & President, Lilly Intl |
• – – |
2019-02-04 |
4 |
A |
$120.17 |
$2,550,488 |
D/D |
21,224 |
67,806 |
0 |
- |
|
| CTS |
CTS Corp |
Director |
– • – |
2019-11-07 |
4 |
A |
$27.81 |
$122,364 |
D/D |
4,400 |
8,600 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & President, Lilly Intl |
• – – |
2020-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
18,322 |
56,646 |
0 |
- |
|
| CTS |
CTS Corp |
Director |
– • – |
2020-11-05 |
4 |
A |
$29.23 |
$122,766 |
D/D |
4,200 |
19,713 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & President, Lilly Intl |
• – – |
2021-02-08 |
4 |
A |
$205.77 |
$5,974,943 |
D/D |
29,037 |
56,947 |
0 |
- |
|
| CTS |
CTS Corp |
Director |
– • – |
2021-11-04 |
4 |
A |
$36.69 |
$132,084 |
D/D |
3,600 |
23,313 |
0 |
- |
|
| SYNH |
Syneos Health Inc |
Director |
– • – |
2022-01-18 |
4 |
A |
$0.00 |
$0 |
D/D |
654 |
654 |
0 |
- |
|
| SYNH |
Syneos Health Inc |
Director |
– • – |
2022-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
2,839 |
3,493 |
0 |
- |
|
| CTS |
CTS Corp |
Director |
– • – |
2022-11-10 |
4 |
A |
$0.00 |
$0 |
D/D |
3,100 |
26,413 |
0 |
- |
|
| SYNH |
Syneos Health Inc |
Director |
– • – |
2023-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
4,863 |
8,356 |
0 |
- |
|
| CTS |
CTS Corp |
Director |
– • – |
2023-11-02 |
4 |
A |
$0.00 |
$0 |
D/D |
3,600 |
30,013 |
0 |
- |
|
| FLAG |
First Light Acquisition G... |
Director |
– • – |
2023-12-21 |
4 |
A |
$1.80 |
$10,159 |
D/D |
5,644 |
133,301 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & President, Lilly Intl |
• – – |
2017-11-10 |
4 |
AS |
$83.67 |
$167,591 |
D/D |
(2,003) |
43,580 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & President, Lilly Intl |
• – – |
2017-12-04 |
4 |
AS |
$86.00 |
$303,752 |
D/D |
(3,532) |
40,048 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & President, Lilly Intl |
• – – |
2018-09-17 |
4 |
AS |
$105.61 |
$316,830 |
D/D |
(3,000) |
55,224 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & President, Lilly Intl |
• – – |
2018-09-18 |
4 |
AS |
$107.00 |
$321,000 |
D/D |
(3,000) |
52,224 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & President, Lilly Intl |
• – – |
2018-10-04 |
4 |
AS |
$114.64 |
$802,480 |
D/D |
(7,000) |
45,224 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & President, Lilly Intl |
• – – |
2019-01-31 |
4 |
AS |
$120.00 |
$480,000 |
D/D |
(4,000) |
41,224 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
SVP & President, Lilly Intl |
• – – |
2019-04-12 |
4 |
AS |
$124.65 |
$1,246,500 |
D/D |
(10,000) |
57,806 |
0 |
- |
|
56 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
